Hypomethylating agents are associated with high rates of hematologic toxicity in patients with secondary myeloid neoplasms developing after acquired aplastic anemia

Haematologica. 2024 Apr 18. doi: 10.3324/haematol.2024.285275. Online ahead of print.ABSTRACTNot available.PMID:38634143 | DOI:10.3324/haematol.2024.285275

Source: Haematologica - April 18, 2024 Category: Hematology Authors: Matthew P Connor Neeharika Prathapa Noelle V Frey Saar I Gill Elizabeth O Hexner Ximena Jordan Bruno Catherine E Lai Alison W Loren Selina M Luger Andrew H Matthews Shannon R McCurdy Alexander E Perl David L Porter Arlene Zeringue Joseph H Oved Timothy S Source Type: research